Public-registry site landscape for NCT07713459, a Lymphoma Nonhodgkin study sponsored by Kure Cells, INC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07713459 (registry record) |
| Sponsor | Kure Cells, INC |
| Condition(s) | Lymphoma Nonhodgkin; Marginal Zone B Cell Lymphoma; Diffuse Large B Cell Lymphoma (DLBCL); Follicular B-cell Non-Hodgkin's Lymphoma |
| Phase | PHASE2 |
| Listed sites | 0 |
Eichor generates a preliminary site-risk snapshot for NCT07713459 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →